RLMD logo

Relmada Therapeutics (RLMD) Cash From Investing

Annual CFI

$50.45 M
+$30.72 M+155.67%

December 31, 2023


Summary


Performance

RLMD Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRLMDcash flowmetrics:

Quarterly CFI

$16.14 M
+$2.13 M+15.19%

September 30, 2024


Summary


Performance

RLMD Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRLMDcash flowmetrics:

TTM CFI

$47.96 M
+$12.28 M+34.43%

September 30, 2024


Summary


Performance

RLMD TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRLMDcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

RLMD Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+155.7%+60.5%+133.8%
3 y3 years+246.5%-41.3%+26.2%
5 y5 years+100.0%--

RLMD Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+193.2%-59.6%+117.7%-31.3%+160.2%
5 y5-yearat high+162.9%-59.6%+117.7%-31.3%+160.2%
alltimeall timeat high+162.9%-59.6%+117.7%-31.3%+160.2%

Relmada Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$16.14 M(+15.2%)
$47.96 M(+34.4%)
Jun 2024
-
$14.01 M(+39.3%)
$35.67 M(+74.0%)
Mar 2024
-
$10.06 M(+29.9%)
$20.51 M(-59.4%)
Dec 2023
$50.45 M(+155.7%)
$7.74 M(+100.5%)
$50.45 M(+22.9%)
Sep 2023
-
$3.86 M(-435.2%)
$41.06 M(-40.3%)
Jun 2023
-
-$1.15 M(-102.9%)
$68.75 M(-1.4%)
Mar 2023
-
$40.00 M(-2516.5%)
$69.76 M(+253.5%)
Dec 2022
$19.73 M(-136.5%)
-$1.66 M(-105.2%)
$19.73 M(-128.3%)
Sep 2022
-
$31.56 M(<-9900.0%)
-$69.79 M(-5.5%)
Jun 2022
-
-$140.50 K(-98.6%)
-$73.84 M(-7.2%)
Mar 2022
-
-$10.03 M(-89.0%)
-$79.61 M(+47.1%)
Dec 2021
-$54.12 M(+57.1%)
-$91.18 M(-431.4%)
-$54.12 M(-242.4%)
Sep 2021
-
$27.51 M(-565.3%)
$38.00 M(+152.0%)
Jun 2021
-
-$5.91 M(-138.2%)
$15.08 M(+224.2%)
Mar 2021
-
$15.47 M(+1553.6%)
$4.65 M(-113.5%)
Dec 2020
-$34.45 M(-57.0%)
$935.30 K(-79.6%)
-$34.45 M(-2.6%)
Sep 2020
-
$4.59 M(-128.1%)
-$35.38 M(-11.5%)
Jun 2020
-
-$16.34 M(-30.9%)
-$39.97 M(+69.1%)
Mar 2020
-
-$23.63 M(<-9900.0%)
-$23.63 M(<-9900.0%)
Dec 2019
-$80.16 M(<-9900.0%)
-
-
Jun 2019
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Mar 2019
-
$0.00(0.0%)
-$9800.00(0.0%)
Dec 2018
-
$0.00(-100.0%)
-$9800.00(-21.0%)
DateAnnualQuarterlyTTM
Jun 2018
-$12.40 K(-75.1%)
-$9800.00(<-9900.0%)
-$12.40 K(+158.3%)
Mar 2018
-
$0.00(0.0%)
-$4800.00(-80.8%)
Dec 2017
-
$0.00(-100.0%)
-$25.00 K(-8.8%)
Sep 2017
-
-$2600.00(+18.2%)
-$27.40 K(-44.8%)
Jun 2017
-$49.70 K(-91.2%)
-$2200.00(-89.1%)
-$49.60 K(-29.5%)
Mar 2017
-
-$20.20 K(+741.7%)
-$70.40 K(-37.9%)
Dec 2016
-
-$2400.00(-90.3%)
-$113.30 K(-80.7%)
Sep 2016
-
-$24.80 K(+7.8%)
-$585.70 K(+4.2%)
Jun 2016
-$562.30 K(+2313.3%)
-$23.00 K(-63.5%)
-$562.20 K(+3.5%)
Mar 2016
-
-$63.10 K(-86.7%)
-$543.10 K(+12.6%)
Dec 2015
-
-$474.80 K(>+9900.0%)
-$482.30 K(+3345.0%)
Sep 2015
-
-$1300.00(-66.7%)
-$14.00 K(-40.2%)
Jun 2015
-$23.30 K(+529.7%)
-$3900.00(+69.6%)
-$23.40 K(+20.0%)
Mar 2015
-
-$2300.00(-64.6%)
-$19.50 K(+13.4%)
Dec 2014
-
-$6500.00(-39.3%)
-$17.20 K(+60.7%)
Sep 2014
-
-$10.70 K(<-9900.0%)
-$10.70 K(+494.4%)
Jun 2014
-$3700.00(+105.6%)
-
-
Feb 2014
-
$0.00(0.0%)
-$1800.00(0.0%)
Nov 2013
-
$0.00(0.0%)
-$1800.00(0.0%)
Aug 2013
-$1800.00(<-9900.0%)
$0.00(-100.0%)
-$1800.00(0.0%)
May 2013
-
-$1800.00(<-9900.0%)
-$1800.00(<-9900.0%)
Feb 2013
-
$0.00(0.0%)
$0.00(0.0%)
Nov 2012
-
$0.00
$0.00
Aug 2012
$0.00
-
-

FAQ

  • What is Relmada Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Relmada Therapeutics?
  • What is Relmada Therapeutics annual CFI year-on-year change?
  • What is Relmada Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Relmada Therapeutics?
  • What is Relmada Therapeutics quarterly CFI year-on-year change?
  • What is Relmada Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Relmada Therapeutics?
  • What is Relmada Therapeutics TTM CFI year-on-year change?

What is Relmada Therapeutics annual cash flow from investing activities?

The current annual CFI of RLMD is $50.45 M

What is the all time high annual CFI for Relmada Therapeutics?

Relmada Therapeutics all-time high annual cash flow from investing activities is $50.45 M

What is Relmada Therapeutics annual CFI year-on-year change?

Over the past year, RLMD annual cash flow from investing activities has changed by +$30.72 M (+155.67%)

What is Relmada Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of RLMD is $16.14 M

What is the all time high quarterly CFI for Relmada Therapeutics?

Relmada Therapeutics all-time high quarterly cash flow from investing activities is $40.00 M

What is Relmada Therapeutics quarterly CFI year-on-year change?

Over the past year, RLMD quarterly cash flow from investing activities has changed by +$6.08 M (+60.50%)

What is Relmada Therapeutics TTM cash flow from investing activities?

The current TTM CFI of RLMD is $47.96 M

What is the all time high TTM CFI for Relmada Therapeutics?

Relmada Therapeutics all-time high TTM cash flow from investing activities is $69.76 M

What is Relmada Therapeutics TTM CFI year-on-year change?

Over the past year, RLMD TTM cash flow from investing activities has changed by +$27.45 M (+133.84%)